News Archive - Page 2 of 23 - Kedrion Biopharma

Choose your country

Find in Kedrion

Expanding Treatment Options: Yimmugo® Coming Soon for PID Patients in the US

Oct 02, 2024 | CORPORATE

Kedrion expands plasma collection network in the Czech Republic

Sep 26, 2024 | PLASMA & BIOTHERAPIES

Kedrion’s focus on advancing patient care in Rare Disease showcased at NBDF Conference 2024

Sep 19, 2024 | EVENTS

Medicines produced by Kedrion from Portuguese plasma now distributed to hospitals by IPST

Jul 09, 2024 | PLASMA & BIOTHERAPIES

Kedrion selected by Biotest to distribute its Immunoglobulin Yimmugo® in the U.S.

Jul 01, 2024 | CORPORATE

100 years of serving patients: our Gödöllő plant, near Budapest celebrates a century of history

May 16, 2024 | CORPORATE

Sixteen years ago, we took over the legacy of a pioneering vaccines and blood derivatives company in Hungary

Kedrion announces RYPLAZIM® now available in US

May 03, 2024 | CORPORATE

Distribution resumes of medicine to treat Congenital Plasminogen Deficiency

Study on the development of therapies produced from plasma waste fractions

Mar 21, 2024 | PLASMA & BIOTHERAPIES

The President and CEO of PPTA visits the Bolognana plant

Mar 11, 2024 | CORPORATE

The meeting was a valuable opportunity for Kedrion and PPTA to strengthen our ongoing partnership

Birth 2023: our commitment to fighting Rh disease between present and future

Dec 21, 2023 | EVENTS

Listen to the podcast

For more information please contact: [email protected]

Title

You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.

Stay